132 related articles for article (PubMed ID: 11574630)
1. Concurrent chemoradiotherapy for squamous cell carcinoma of thoracic esophagus: feasibility and outcome of large regional field and high-dose external beam boost irradiation.
Toita T; Ogawa K; Adachi G; Kakinohana Y; Nishikuramori Y; Iraha S; Utsunomiya T; Murayama S
Jpn J Clin Oncol; 2001 Aug; 31(8):375-81. PubMed ID: 11574630
[TBL] [Abstract][Full Text] [Related]
2. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant concurrent chemoradiotherapy followed by definitive high-dose radiotherapy or surgery for operable thoracic esophageal carcinoma.
Murakami M; Kuroda Y; Okamoto Y; Kono K; Yoden E; Kusumi F; Hajiro K; Matsusue S; Takeda H
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1049-59. PubMed ID: 9539559
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinoma.
Yorozu A; Dokiya T; Oki Y
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):271-5. PubMed ID: 10487545
[TBL] [Abstract][Full Text] [Related]
5. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
6. Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula.
Nishimura Y; Suzuki M; Nakamatsu K; Kanamori S; Yagyu Y; Shigeoka H
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):134-9. PubMed ID: 12007951
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
8. [Concurrent chemoradiation with paclitaxel and platinum for locally advanced esophageal cancer].
Zhang P; Xie CY; Wu SX
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):773-7. PubMed ID: 18396692
[TBL] [Abstract][Full Text] [Related]
9. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.
Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg R; Benson A
J Clin Oncol; 1996 Jan; 14(1):149-55. PubMed ID: 8558190
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of concurrent chemoradiotherapy with daily-low-dose continuous infusion of 5-fluorouracil and cisplatin (LDFP) for Stage I-II esophageal carcinoma.
Kumabe A; Fukada J; Kota R; Koike N; Shiraishi Y; Seki S; Yoshida K; Kitagawa Y; Shigematsu N
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29228166
[TBL] [Abstract][Full Text] [Related]
13. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus.
Ohtsu A; Boku N; Muro K; Chin K; Muto M; Yoshida S; Satake M; Ishikura S; Ogino T; Miyata Y; Seki S; Kaneko K; Nakamura A
J Clin Oncol; 1999 Sep; 17(9):2915-21. PubMed ID: 10561371
[TBL] [Abstract][Full Text] [Related]
14. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost.
Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R
Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518
[TBL] [Abstract][Full Text] [Related]
15. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
[TBL] [Abstract][Full Text] [Related]
16. Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study.
Wang D; Yang J; Zhu J; Li B; Zhai L; Sun M; Gong H; Zhou T; Wei Y; Huang W; Wang Z; Li H; Zhang Z
Radiat Oncol; 2013 May; 8():108. PubMed ID: 23638721
[TBL] [Abstract][Full Text] [Related]
17. Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma.
Caro M; Font A; Comas S; Viciano M; Remon J; Céliz P; Robles J; Musulén E; Sendrós MJ; Mesalles E; Jiménez JA; Boix J; Arellano A; Fernández-Llamazares J
Clin Transl Oncol; 2016 Nov; 18(11):1106-1113. PubMed ID: 26856597
[TBL] [Abstract][Full Text] [Related]
18. [Concurrent chemoradiotherapy for T4 and/or M1 LYM squamous cell carcinoma of the esophagus].
Miyata Y; Seki S; Ohtsu A; Kaneko K; Nakamura A
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1174-9. PubMed ID: 10945013
[TBL] [Abstract][Full Text] [Related]
19. Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.
Minsky BD; Neuberg D; Kelsen DP; Pisansky TM; Ginsberg RJ; Pajak T; Salter M; Benson AB
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):517-23. PubMed ID: 10078631
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
